|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows - operating activities: | |||||
| Net income including noncontrolling interests | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of identifiable intangible assets | |||||
| Provision for credit losses | |||||
| Deferred income taxes | |||||
| Gain on sale of United Kingdom operations | |||||
| Gain on sale or disposal of property, plant, and equipment | |||||
| Excess tax benefits from share-based compensation | |||||
| Equity income from unconsolidated entities | |||||
| Non-cash expense for amortization of debt issuance costs | |||||
| Non-cash (income) expense from contingent consideration arrangements | |||||
| Non-cash expense for impairment of long-lived assets | |||||
| Non-cash share-based compensation expense | |||||
| Distributions from unconsolidated entities | |||||
| Changes in operating assets and liabilities, excluding the effect of businesses acquired: | |||||
| Increase in accounts receivable | |||||
| (Increase) decrease in inventories | |||||
| (Increase) decrease in contract assets | |||||
| Increase (decrease) in accounts payable | |||||
| Increase in contract liabilities | |||||
| Increase in accrued payroll and benefits and other accrued expenses and liabilities | |||||
| Changes in other assets and liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows - investing activities: | |||||
| Payments for acquisitions of businesses, net of cash acquired | |||||
| Net proceeds from sale of United Kingdom operations | |||||
| Proceeds from sale or disposal of property, plant, and equipment | |||||
| Purchases of property, plant, and equipment | |||||
| Investments in and advances to unconsolidated entities | |||||
| Distributions from unconsolidated entities | |||||
| Net cash used in investing activities | |||||
| Cash flows - financing activities: | |||||
| Proceeds from revolving credit facility | |||||
| Repayments of revolving credit facility | |||||
| Repayments of long-term debt and debt issuance costs | |||||
| Repayments of finance lease liabilities | |||||
| Dividends paid to stockholders | |||||
| Repurchases of common stock | |||||
| Taxes paid related to net share settlements of equity awards | |||||
| Issuances of common stock under employee stock purchase plan | |||||
| Payments for contingent consideration arrangements | |||||
| Distributions to noncontrolling interests | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| (Decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of year (1) | |||||
| Cash, cash equivalents, and restricted cash at end of period (1) | |||||
Loading...